All news
High ImpactPharma

Senores Pharma reappoints MD Swapnil Shah

Senores Pharma reappoints MD Swapnil Shah. The board reappointed Mr. Swapnil Jatinbhai Shah as Managing Director. The decision was approved on October 13, 2026. No financial impact is expected from this routine corporate action.

📊 STOCKS: $SENORES | 🏢 SECTOR: Pharma | #LOWIMPACT #Leadership

#Leadership#Reappointment#Corporate
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.